Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Cyberonics, Inc.'s financial performance into perspective.

Recent Releases

May 7, 2013
Cyberonics To Report Fourth Quarter And Fiscal Year 2013 Results And Host Webcast And Conference Call On June 5, 2013

Apr 4, 2013
Cyberonics Provides Update On Submission To CMS

View all releases »

Events & Presentations

Jun 5, 2013 at 9:00 AM ET
Cyberonics Earnings Conference Call - Q4 FY2013 Results

View all events & presentations »